Visfatin: the missing link between intra-abdominal obesity and diabetes?
about
Role of adiponectin and some other factors linking type 2 diabetes mellitus and obesityExtracellular nicotinamide phosphoribosyltransferase, a new cancer metabokineLow circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection.Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity.Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells.Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents.Increased serum visfatin as a risk factor for atherosclerosis in patients with ischaemic cerebrovascular disease.Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?Roles of physical activity and cardiorespiratory fitness on sex difference in insulin resistance in late elementary years.Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.Adipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measuresChanges in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.Effects of basal insulin application on serum visfatin and adiponectin levels in type 2 diabetes.The effect of physical activity on serum IL-6 and vaspin levels in late elementary school children.Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.Adipocyte nuclei captured from VAT and SATMaternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate.Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at termRelationship of visfatin level to pancreatic endocrine hormone level, HOMA-IR index, and HOMA β-cell index in overweight women who performed hydraulic resistance exercise.Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis.Maternal visfatin concentration in normal pregnancy.Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?Dysregulation of maternal serum adiponectin in preterm laborThematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation.Nutrigenomics, beta-cell function and type 2 diabetesCross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective.Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition.Visfatin level in patients with colorectal adenoma.Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36.Atorvastatin antagonizes the visfatin-induced expression of inflammatory mediators via the upregulation of NF-κB activation in HCAECs.Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart.Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.Reviews: adipocytokines in normal and complicated pregnancies.Genetic associations of the visfatin G-948T polymorphism with obesity-related metabolic traits in an Iranian population.Bariatric surgery, bone loss, obesity and possible mechanisms.Biomarkers in the field of obesity and its related comorbidities.Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations.Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappaB pathway.
P2860
Q26777653-C205AB9E-6FD2-477B-838E-DE9B4CB485B2Q28069876-C26EC95E-DC22-49FB-826F-BAC7525570FFQ33575629-B778AB65-E549-4860-8E84-7CB085F0AEFDQ34022206-23A2E4C4-DF05-4E8E-BB0B-EB4DC991DB7CQ34235479-E301652B-2644-457C-8E21-EF8D92904523Q34488394-B848DC44-7E55-4863-8573-3BD26FE2586CQ34539655-4117C673-8CC0-46E8-83F5-D584432DB5A6Q34929150-B4213A1D-153E-4CE2-AD16-10A95C8A0AFDQ34993305-1DB38E77-397A-4D8A-8D86-8E2DDBCF00D6Q35064815-46302487-0711-4D65-8278-C743BD177903Q35200808-A1A077D7-1E8F-4C70-B9A4-7CA51AE6E2F1Q35540694-B0419126-8001-4444-B2EB-7636FF25B1EDQ35637875-50F7A72D-D040-4BD3-A7D8-CFD64714B1AFQ35758165-B14D5754-297E-497B-B18B-CBC52A6F162DQ35913180-97295865-EC45-4193-B695-24DA91CED732Q36014103-F8842EF0-7F26-42A8-9851-A5BAC0929D0DQ36086937-C590A117-EC57-4944-A4B4-97C5DBA9FA3EQ36145631-EF6AAA51-F85C-44E0-84E7-97D81EFAB5B6Q36179324-B5F6881B-7B79-4601-AB19-25BCC926BD14Q36192889-94CD302A-A9B5-4241-A40A-FEB618318994Q36283981-664E4F71-7097-430C-AC5A-980A52B28004Q36406577-BE24251A-EF8E-4393-B505-96DA6458A449Q36419240-6D434562-EE9C-445B-9B2A-52ACCD475A70Q36560160-FBB6963E-BDAB-478B-AF3C-C43A4EBB2DDCQ36692476-BE43556C-3FBF-4382-81B6-C1C0173F8C0DQ36765385-56EB0DE4-963C-4367-9C8D-72A572F2BCB2Q36775874-81AF510B-465E-4DE8-9DD9-BC7F611181BBQ36938546-C729E137-05DB-4FBA-B5C3-29871B9804AAQ36968586-E4F77ECC-43EC-4673-8C57-383DAEC749D7Q36983311-76148E1C-5A10-41DF-AD26-7211B8FA113EQ37099456-D5ACE564-5474-4CBE-B793-25EA43854174Q37107942-433DADCE-5E68-4737-89B7-E83549B4994FQ37161801-4881A3A7-A04A-47E2-A097-549B5367CCB8Q37324960-F0EAD2DF-3005-4000-9378-90A22FEDB2C6Q37497870-7FF6C838-67AB-4CB9-9A41-597281C26AD7Q37661612-3CD6432A-1559-4D8E-85F8-F8377C61DF66Q38055242-9F7605D4-9143-417C-9BE2-B2BC638C42AFQ38183431-8BBF2F96-251C-4CDC-8E3A-DD5B0D35DEF3Q38763702-5E7183D8-3561-42AD-86BC-FE45F887D7CFQ39882720-CE3F7D8B-36BF-4AE8-ADA5-610A1B2C9291
P2860
Visfatin: the missing link between intra-abdominal obesity and diabetes?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Visfatin: the missing link between intra-abdominal obesity and diabetes?
@ast
Visfatin: the missing link between intra-abdominal obesity and diabetes?
@en
type
label
Visfatin: the missing link between intra-abdominal obesity and diabetes?
@ast
Visfatin: the missing link between intra-abdominal obesity and diabetes?
@en
prefLabel
Visfatin: the missing link between intra-abdominal obesity and diabetes?
@ast
Visfatin: the missing link between intra-abdominal obesity and diabetes?
@en
P2860
P1476
Visfatin: the missing link between intra-abdominal obesity and diabetes?
@en
P2093
Antonio Vidal-Puig
P2860
P304
P356
10.1016/J.MOLMED.2005.06.010
P577
2005-08-01T00:00:00Z